CN102533951B - 一种brap与psma6基因snp检测特异性引物和液相芯片 - Google Patents
一种brap与psma6基因snp检测特异性引物和液相芯片 Download PDFInfo
- Publication number
- CN102533951B CN102533951B CN201010590998.7A CN201010590998A CN102533951B CN 102533951 B CN102533951 B CN 102533951B CN 201010590998 A CN201010590998 A CN 201010590998A CN 102533951 B CN102533951 B CN 102533951B
- Authority
- CN
- China
- Prior art keywords
- seq
- sequence
- gene
- brap
- psma6
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 101150085788 Psma6 gene Proteins 0.000 title claims abstract description 39
- 101150080808 Brap gene Proteins 0.000 title claims abstract description 38
- 238000001514 detection method Methods 0.000 title claims abstract description 34
- 239000007791 liquid phase Substances 0.000 title claims abstract description 28
- 102100027106 BRCA1-associated protein Human genes 0.000 title claims abstract 9
- 241000183024 Populus tremula Species 0.000 claims abstract description 34
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 9
- 101000984746 Homo sapiens BRCA1-associated protein Proteins 0.000 claims description 18
- 101000944524 Homo sapiens Bombesin receptor-activated protein C6orf89 Proteins 0.000 claims description 18
- 230000000295 complement effect Effects 0.000 claims description 4
- 239000003086 colorant Substances 0.000 claims description 3
- 101150076401 16 gene Proteins 0.000 claims 3
- 102220007500 rs387906544 Human genes 0.000 abstract description 8
- 102220037837 rs76224028 Human genes 0.000 abstract description 8
- 238000012163 sequencing technique Methods 0.000 abstract description 7
- 230000003321 amplification Effects 0.000 abstract description 3
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 3
- 239000004005 microsphere Substances 0.000 abstract description 2
- 102100033680 Bombesin receptor-activated protein C6orf89 Human genes 0.000 description 25
- 238000000034 method Methods 0.000 description 15
- 239000012530 fluid Substances 0.000 description 13
- 230000008859 change Effects 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 238000013461 design Methods 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 238000009396 hybridization Methods 0.000 description 9
- 102100034664 Proteasome subunit alpha type-6 Human genes 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 101001090813 Homo sapiens Proteasome subunit alpha type-6 Proteins 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- 230000000869 mutational effect Effects 0.000 description 6
- 102000004083 Lymphotoxin-alpha Human genes 0.000 description 5
- 108090000542 Lymphotoxin-alpha Proteins 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 239000011550 stock solution Substances 0.000 description 5
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000013016 damping Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 206010064571 Gene mutation Diseases 0.000 description 3
- 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 3
- 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 102000044159 Ubiquitin Human genes 0.000 description 3
- 108090000848 Ubiquitin Proteins 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000007403 mPCR Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 230000006663 ubiquitin-proteasome pathway Effects 0.000 description 2
- VLEIUWBSEKKKFX-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O VLEIUWBSEKKKFX-UHFFFAOYSA-N 0.000 description 1
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
- 108700020463 BRCA1 Proteins 0.000 description 1
- 102000036365 BRCA1 Human genes 0.000 description 1
- 101150072950 BRCA1 gene Proteins 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108010077850 Nuclear Localization Signals Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 101710186646 Proteasome subunit alpha type-6 Proteins 0.000 description 1
- 101150093221 RAP gene Proteins 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 102000018478 Ubiquitin-Activating Enzymes Human genes 0.000 description 1
- 108010091546 Ubiquitin-Activating Enzymes Proteins 0.000 description 1
- 230000030741 antigen processing and presentation Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 210000000497 foam cell Anatomy 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- -1 polyoxyethylene Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
序号 | 基因 | BRAP与PSMA6位点突变的内容 | 简写 |
1 | BRAP | SEQ ID NO.25的第96位核苷酸,发生A→G突变 | A96G |
2 | SEQ ID NO.26的第80位核苷酸,发生A→G突变 | A80G | |
3 | PSMA6 | SEQ ID NO.27的第157位核苷酸,发生C→G突变 | C157G |
试剂 | 来源 | 终浓度 | 每250ml的用量 |
1MTris-HCl,pH8.0 | SigmaT3038 | 0.2M | 50ml |
5M NaCl | Sigma S5150 | 0.4M | 20ml |
Triton X-100 | Sigma T8787 | 0.16% | 0.4ml |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010590998.7A CN102533951B (zh) | 2010-12-16 | 2010-12-16 | 一种brap与psma6基因snp检测特异性引物和液相芯片 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010590998.7A CN102533951B (zh) | 2010-12-16 | 2010-12-16 | 一种brap与psma6基因snp检测特异性引物和液相芯片 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102533951A CN102533951A (zh) | 2012-07-04 |
CN102533951B true CN102533951B (zh) | 2014-01-01 |
Family
ID=46341978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010590998.7A Expired - Fee Related CN102533951B (zh) | 2010-12-16 | 2010-12-16 | 一种brap与psma6基因snp检测特异性引物和液相芯片 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102533951B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103865990B (zh) * | 2012-12-14 | 2016-05-18 | 益善生物技术股份有限公司 | Cdkn1b基因突变检测特异性引物和液相芯片 |
CN105969859A (zh) * | 2016-05-13 | 2016-09-28 | 深圳市核子基因科技有限公司 | 乳腺癌易感基检测芯片及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101805798A (zh) * | 2010-04-09 | 2010-08-18 | 广州益善生物技术有限公司 | Cyp2e1基因snp检测特异性引物、液相芯片和检测方法 |
CN101812511A (zh) * | 2009-12-29 | 2010-08-25 | 广州益善生物技术有限公司 | 一种cyp3a4基因snp检测特异性引物、液相芯片及方法 |
-
2010
- 2010-12-16 CN CN201010590998.7A patent/CN102533951B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101812511A (zh) * | 2009-12-29 | 2010-08-25 | 广州益善生物技术有限公司 | 一种cyp3a4基因snp检测特异性引物、液相芯片及方法 |
CN101805798A (zh) * | 2010-04-09 | 2010-08-18 | 广州益善生物技术有限公司 | Cyp2e1基因snp检测特异性引物、液相芯片和检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102533951A (zh) | 2012-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102010906B (zh) | 一种embB基因突变检测特异性引物和液相芯片 | |
CN102154455B (zh) | 一种cyp2c9基因snp检测特异性引物和液相芯片 | |
CN102533948B (zh) | 一种apoB基因SNP检测特异性引物和液相芯片 | |
CN102134605B (zh) | 一种cyp2c19基因snp检测特异性引物和液相芯片 | |
CN102021238B (zh) | Adrb1基因snp检测特异性引物和液相芯片 | |
CN102533951B (zh) | 一种brap与psma6基因snp检测特异性引物和液相芯片 | |
CN102021240B (zh) | 一种gstm1、gstt1和gstp1基因突变检测液相芯片 | |
CN103374609B (zh) | Abo基因突变检测特异性引物和液相芯片 | |
CN102021237B (zh) | Cyp4f2和ephx1基因snp检测液相芯片以及特异性引物 | |
CN102277413B (zh) | Cox-1基因snp检测特异性引物和液相芯片 | |
CN102010907B (zh) | katG、inhA和ndh基因突变检测特异性引物和液相芯片 | |
CN102021236B (zh) | Agt1r基因snp检测液相芯片和特异性引物 | |
CN102010898B (zh) | Ephx1基因检测特异性引物和液相芯片 | |
CN102533947B (zh) | 一种kcnq1、kcne2与kcnn3基因snp检测特异性引物和液相芯片 | |
CN102533954B (zh) | 一种cyp17a1基因多态性检测特异性引物和液相芯片 | |
CN102533953B (zh) | 一种lpl基因snp检测特异性引物和液相芯片 | |
CN102994620B (zh) | 一种akt1基因突变检测特异性引物和液相芯片 | |
CN102010900B (zh) | GPIIIa和COX-1基因SNP检测液相芯片以及特异性引物 | |
CN103031367A (zh) | 一种vhl基因突变检测特异性引物和液相芯片 | |
CN102912006B (zh) | 一种cyp2a6基因多态性检测特异性引物和液相芯片 | |
CN102559850B (zh) | 一种apoA5基因突变检测特异性引物和液相芯片 | |
CN102952866B (zh) | 一种dpyd基因多态性检测特异性引物和液相芯片 | |
CN102559851B (zh) | 一种stk39基因snp检测特异性引物和液相芯片 | |
CN101962686B (zh) | 一种rpoB基因突变检测特异性引物和液相芯片 | |
CN102533949B (zh) | 一种染色体4q25区段SNP检测特异性引物和液相芯片 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: Five 510663 Guangdong city of Guangzhou province Guangzhou Science City Moon Road No. 80, Guangzhou technology innovation base B, C Applicant after: SUREXAM BIO-TECH Co.,Ltd. Address before: Five 510663 Guangdong city of Guangzhou province Guangzhou Science City Moon Road No. 80, Guangzhou technology innovation base B, C Applicant before: GUANGZHOU SUREXAM BIO-TECH Co.,Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: GUANGZHOU YISHAN BIOTECHNOLOGY CO., LTD. TO: SUREXAM BIOTECHNOLOGY CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140101 |